Ganoderma lucidum polysaccharide is a secondary metabolite of the mycelium of the Ganoderma genus fungus of the Polyporaceae family, and exists in the mycelium and fruiting bodies of the Ganoderma genus fungus. The Ganoderma lucidum fruiting bodies are crushed and added with a small amount of culture medium for fermentation. After fermentation, the raw materials are centrifuged, the supernatant is vacuum concentrated at low temperature, dialyzed, ethanol precipitated, washed with acetone, protein removed, spray dried, and finally 10% water is added to extract the dry powder and mixed. Ganoderma lucidum polysaccharide is a light brown to brown powder, soluble in hot water.
Ganoderma lucidum polysaccharide has many pharmacological activities: it can improve the body’s immunity, accelerate blood microcirculation, improve blood oxygen supply capacity, reduce the body’s ineffective oxygen consumption in a static state, eliminate free radicals in the body, improve the body’s cell membrane closure, resist radiation, improve the liver, bone marrow, blood synthesis of DNA, RNA, protein ability, prolong life, etc. Most of the various pharmacological activities of Ganoderma lucidum are related to Ganoderma lucidum polysaccharide.
Functions: Lowering blood sugar, lowering blood lipids, anti-thrombosis, anti-oxidation, scavenging free radicals, anti-aging, anti-radiation, anti-tumor, promoting blood circulation, regulating immunity, regulating nucleic acid and protein metabolism, promoting DNA synthesis, and promoting the proliferation of human umbilical cord blood LAK cells.
